Diligence memo · auto-generated · as of July 2, 2026
aMBR Genomics, Inc.
aMBR Genomics, Inc. has raised $1.1M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
aMBR Genomics, Inc. operates in Biotech, based in MADISON.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
aMBR Genomics, Inc. has raised $1.1M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.1M on 2025-10-21.
Most recent recorded round closed around 2025-10-21.
Valuation (modeled)modeled
Provath models aMBR Genomics, Inc. at approximately $2.6M (range $792K–$4.8M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 8 mo ago; this sector typically re-raises about every 11 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 74% of Biotech peers (233 compared).
Modeled value ranks above 71% of those peers.
Closest niche peers: Primary Bioscience, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.